Cargando…
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma
PURPOSE: When brain cancer relapses, treatment options are scarce. The use of molecularly matched targeted therapies may provide a feasible and efficacious way to treat individual patients based on the molecular tumor profile. Since little information is available on this strategy in neuro-oncology,...
Autores principales: | Lazaridis, Lazaros, Schmidt, Teresa, Oster, Christoph, Blau, Tobias, Pierscianek, Daniela, Siveke, Jens T., Bauer, Sebastian, Schildhaus, Hans-Ulrich, Sure, Ulrich, Keyvani, Kathy, Kleinschnitz, Christoph, Stuschke, Martin, Herrmann, Ken, Deuschl, Cornelius, Scheffler, Björn, Kebir, Sied, Glas, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314879/ https://www.ncbi.nlm.nih.gov/pubmed/35953681 http://dx.doi.org/10.1007/s00432-022-04050-w |
Ejemplares similares
-
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma
por: Schmidt, Teresa, et al.
Publicado: (2023) -
Telemedicine in Neuro-Oncology—An Evaluation of Remote Consultations during the COVID-19 Pandemic
por: Feldheim, Jonas, et al.
Publicado: (2023) -
Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report
por: Stoppek, Ann-Kathrin, et al.
Publicado: (2019) -
Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma
por: Schmidt, Teresa, et al.
Publicado: (2021) -
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005–2022
por: Oster, Christoph, et al.
Publicado: (2023)